Trials / Terminated
TerminatedNCT03740880
Trigger Time in Advanced Maternal Age Patients With Low AMH
Pilot Study: Optimal Trigger Time in Advanced Maternal Age Patients With Low AMH
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- ART Fertility Clinics LLC · Academic / Other
- Sex
- Female
- Age
- 40 Years – 48 Years
- Healthy volunteers
- Accepted
Summary
The investigators want to verify if advanced maternal age patients with a low Anti-Müllerian hormone (AMH) level may benefit from an early trigger time (compared to a late trigger).
Detailed description
During assisted reproduction, patients are stimulated in order to achieve a multifollicular development. The final step in this stimulation process is "the trigger" that will induce the final maturation of the oocytes. This timing is historically put once at least one follicle of 16-17 mm is obtained. When looking at poor ovarian responder (POR) patients (characterized by a low AMH), the investigators observe shorter menstrual cycles and thus it is thought that the oocyte selected for ovulation, will also mature faster. This observation may indicate that POR patients potentially do not benefit from a trigger performed once a leading follicle of 17 mm is present, but rather from an earlier trigger. The main objective is to analyse if an early trigger (leading follicle of 14 mm) results in the same maturation rate in POR patient as compared to a late trigger (17 mm). As the embryos will be cultured in a time lapse imaging system, annotations on the developmental kinetics can be made and the differences in fertilization rate and embryo development can be analysed as secondary outcome parameter. On top of this, patients will undergo a genetic testing of their embryos and this genetic analysis , together with the mtDNA copy number will also be compared between patients with early or late trigger. Euploid blastocysts will be transferred in subsequent frozen embryo transfer (FET) cycles and give an indication on the clinical outcome between IVF and ICSI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dual trigger | dual trigger: 10.000 IU hCG i.m. and 0.3 mg Deca |
Timeline
- Start date
- 2019-01-07
- Primary completion
- 2020-03-12
- Completion
- 2020-03-30
- First posted
- 2018-11-14
- Last updated
- 2022-03-04
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT03740880. Inclusion in this directory is not an endorsement.